Patient Education Sheet Library
Search Results
Downloads:
Download (English) – 0.36 MBAzacitidine and Venetoclax
The combination of azacitidine and venetoclax is used for acute myeloid leukemia (AML).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Downloads:
Trastuzumab Deruxtecan and Pertuzumab
The combination of trastuzumab deruxtecan and pertuzumab is used for breast cancer.
Treatment Given by InfusionDownloads:
Atezolizumab and Lurbinectedin
The combination of atezolizumab and lurbinnectedin is used for small cell lung cancer.
Treatment Given by InfusionDownloads:
Eculizumab
Eculizumab is used for paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Treatment Given by InfusionDownloads:
Axatilimab
Axatilimab is used for chronic graft‑versus-host disease (cGVHD).
Treatment Given by InfusionDownloads:
Filgrastim
Filgrastim is used to help reduce the chance of infection due to a low white…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Sirolimus Protein-Bound Particles
Sirolimus protein-bound particles are used for malignant perivascular epithelioid cell tumors (PEComa).
Treatment Given by InfusionDownloads:
Encorafenib, Cetuximab and FOLFOX
The combination of encorafenib, cetuximab, and FOLFOX (leucovorin, fluorouracil (5-FU), and oxaliplatin) is used for…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
